Apple Inc. litigation

bp, First National Bank of Omaha Introduce BPme Rewards Visa® with Elevated Rewards and Savings

Retrieved on: 
Tuesday, July 12, 2022

CHICAGO, July 12, 2022 /PRNewswire/ -- bp today announced the launch of the new BPme Rewards Signature Visa® Credit Card in conjunction with First National Bank of Omaha (FNBO) and Visa. The new BPme Rewards Visa introduces a modern take on the traditional fuel card, improving customer benefits by combining the power of BPme Rewards with traditional credit card advantages, like cash back rewards and flexible redemption options.

Key Points: 
  • CHICAGO, July 12, 2022 /PRNewswire/ -- bp today announced the launch of the new BPme Rewards Signature Visa Credit Card in conjunction with First National Bank of Omaha (FNBO) and Visa.
  • The new BPme Rewards Visa introduces a modern take on the traditional fuel card, improving customer benefits by combining the power of BPme Rewards with traditional credit card advantages, like cash back rewards and flexible redemption options.
  • The BPme Rewards Visa is an enhanced credit card offer built upon the existing BPme Rewards loyalty program.
  • Cards are issued by First National Bank of Omaha (FNBO), pursuant to a license from Visa U.S.A. Inc. Visa and Visa Signature are registered trademarks of Visa
    International Service Association and used under license.

Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years

Retrieved on: 
Tuesday, September 14, 2021

Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003.

Key Points: 
  • Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003.
  • A winner of the World Economic Forum Technology Pioneer Award, the Company developed and is commercializing its lead product ACP-01 for the treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and other conditions of ischemia.
  • Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation.
  • This forward-looking information reflects Hemostemix's current beliefs and is based on information currently available to Hemostemix and on assumptions Hemostemix believes are reasonable.

Vivint Issues Statement on ADT Patent Infringement Lawsuit

Retrieved on: 
Wednesday, June 30, 2021

On June 29, 2021, ADT filed a complaint against Vivint, a leading smart home company, in the U.S. District Court for the Western District of Texas and a companion case with the U.S. International Trade Commission claiming that Vivint infringed two ADT patents.

Key Points: 
  • On June 29, 2021, ADT filed a complaint against Vivint, a leading smart home company, in the U.S. District Court for the Western District of Texas and a companion case with the U.S. International Trade Commission claiming that Vivint infringed two ADT patents.
  • Vivint believes the claims asserted are completely without merit and that the complaint is a reactionary countersuit to a patent infringement complaint Vivint had previously filed on February 25, 2021 against ADT in the U.S. District Court for the District of Utah.
  • Vivints complaint asserts that ADT infringes six Vivint patents and Vivint is continuing to prosecute its claims in that case.
  • Vivint Smart Home is a leading smart home company in North America.

Apple Tower Theatre Opens Thursday in Downtown Los Angeles

Retrieved on: 
Tuesday, June 22, 2021

Apple today previewed its newest retail location at the historic Tower Theatre in downtown Los Angeles.

Key Points: 
  • Apple today previewed its newest retail location at the historic Tower Theatre in downtown Los Angeles.
  • One of Apples most significant restoration projects to date, Apple Tower Theatre aims to inspire even more creativity in the heart of downtown.
  • Apple Tower Theatre is Apples 26th location in greater Los Angeles.
  • Apple, Apple TV+, Today at Apple, iMac, iPad Pro, Apple TV 4K, Genius Bar, Apple Store, and the Apple logo are trademarks of Apple.

Apple Launches Today at Apple Creative Studios to Provide Opportunities to Young Creatives

Retrieved on: 
Tuesday, June 22, 2021

Today at Apple will also offer public sessions open to anyone, led by the inspiring artists who are providing mentorship experiences to the young participants in Today at Apple Creative Studios.

Key Points: 
  • Today at Apple will also offer public sessions open to anyone, led by the inspiring artists who are providing mentorship experiences to the young participants in Today at Apple Creative Studios.
  • Today at Apple Creative Studios - LA focuses on developing the talents of young musicians.
  • Today at Apple Creative Studios builds on Apples history of providing free educational programming in Apple Store locations worldwide through Today at Apple, and career development opportunities through programs such as the Community Education Initiative.
  • Apple, iPhone, iPad, Mac, Apple Store, Today at Apple, Apple Pencil, GarageBand, Apple Music, iMovie, and the Apple logo are trademarks of Apple.

Immervision Wins Patent Challenge Against LG Electronics

Retrieved on: 
Tuesday, June 1, 2021

Immervision, inventor of wide-angle optical design with distortion control and leader in designing advanced vision systems, today announced it has successfully defended its patent against challenges made by LG Electronics.

Key Points: 
  • Immervision, inventor of wide-angle optical design with distortion control and leader in designing advanced vision systems, today announced it has successfully defended its patent against challenges made by LG Electronics.
  • In November 2019, LG petitioned the Patent Trial and Appeal Board, challenging the validity of one of Immervisions key patents (U.S. Patent No.
  • In 2018, Immervision filed a civil complaint against LG for patent infringement over several Smartphone models with wide-angle camera technology.
  • LG responded by challenging the validity of Immervisions patent at the United States Patent and Trademark Office.

Pictos Technologies Files Lawsuit in Texas Against Samsung Alleging Patent Infringement and Theft of Trade Secrets

Retrieved on: 
Monday, May 24, 2021

Samsung, the worlds largest manufacturer of smartphones, was today served with a lawsuit by Pictos Technologies, Inc. seeking damages for Samsungs infringement of Pictoss patented digital imaging technology.

Key Points: 
  • Samsung, the worlds largest manufacturer of smartphones, was today served with a lawsuit by Pictos Technologies, Inc. seeking damages for Samsungs infringement of Pictoss patented digital imaging technology.
  • Pictos filed its complaint in the United States District Court for the Eastern District of Texas, Sherman Division alleging that Samsung Austin Semiconductor, LLC, Samsung Electronics Co., Ltd., Samsung Electronics America, Inc., and Samsung Semiconductor, Inc. engaged in industrial espionage, violated non-disclosure agreements and has infringed Pictos patents.
  • These actions, Pictos alleges, destroyed its camera sensor business and continues to cause Pictos harm.
  • Senator Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, has been outspoken on free and fair trade.

Olympus Files Patent Infringement Lawsuit Against Cantel/Medivators

Retrieved on: 
Monday, March 22, 2021

CENTER VALLEY, Pa., March 22, 2021 /PRNewswire/ -- Today, Olympus Corporation of the Americas announced its filing of litigation in which Olympus accuses Cantel/Medivators of violating patents related to colonoscopy assist devices.

Key Points: 
  • CENTER VALLEY, Pa., March 22, 2021 /PRNewswire/ -- Today, Olympus Corporation of the Americas announced its filing of litigation in which Olympus accuses Cantel/Medivators of violating patents related to colonoscopy assist devices.
  • The complaint alleges that the manufacture, sale and distribution of the AmplifEye Endoscopic Device infringes on two patents held by Olympus for its ENDOCUFF single-use devices.
  • This lawsuit follows the finding by the High Court of Justice England and Wales, Patent Court that the ENDOCUFF and ENDOCUFF VISION UK national and UK(EP) patents (as amended) were infringed by the AmplifEyeTM Endoscopic Device.
  • The family of ENDOCUFF products and the patents that protect those products were fully acquired in summer 2020 with the Olympus acquisition of Arc Medical Design.

Fish & Richardson's District Court Victory in Samsung Patent Lawsuit Sustained on Appeal With Precedential Federal Circuit Opinion

Retrieved on: 
Thursday, March 11, 2021

The Federal Circuit also dismissed Rain Computing's appeal of a final judgment of noninfringement as moot.

Key Points: 
  • The Federal Circuit also dismissed Rain Computing's appeal of a final judgment of noninfringement as moot.
  • Rain Computing sued Samsung in 2018 in the United States District Court for the District of Massachusetts, alleging that Samsung's Galaxy smartphones infringed claims of U.S. Patent No.
  • The district court found that the asserted claims were neither infringed nor invalid for indefiniteness, prompting Rain to appeal and Samsung to cross-appeal the decision to the Federal Circuit.
  • The Fish team representing Samsung in the district court and on appeal included Michael McKeon and Christopher Dryer.

Illinois US District Court Sides with Hytera to Significantly Lower Damage Award

Retrieved on: 
Thursday, January 21, 2021

The jury verdict, including the original damage award, was made on February 14th, 2020; and the Court entered judgment on March 5th, 2020.

Key Points: 
  • The jury verdict, including the original damage award, was made on February 14th, 2020; and the Court entered judgment on March 5th, 2020.
  • The Court also denied Motorola Solutions' request for supplemental damages, while granted the request for interest on the monetary award.
  • Meanwhile, on January 11, Hytera won the appeal against Motorola over the freezing orderinthe UK court proceedings.
  • Since March 2020, Hytera has presented substantive post-trial motions to the U.S. District Court for the Northern District of Illinois over the merits of Motorola's claims and evidentiary and legal errors at the trial.